Chlamydia (CT) and Gonorrhea (NG)

More than 4 million Americans contract these diseases annually. While most can be treated with antibiotics, a condition left untreated can cause pelvic inflammatory disease, complications with pregnancy.

In a study by the University of Michigan Health System Gonorrhea has been linked to prostate cancer in men.

CMCD utilizes the molecular method, nucleic acid amplification test (NAAT) the current preferred method of testing for CT and NG. We are able to perform the test from a Thin Prep Pap sample or urine, making it less invasive for your patient.

Collection Method

Specimen Requirements: (All Women’s Health Tests performed on SINGLE Sample) Testing Volume/Size: 1 mL;
Type: Cervical;
Container: Thin Prep;

Transport Temperature: Ambient;
Turn Around Time: 48 – 72 hours from receipt of specimen in laboratory

More than 4 million Americans contract Chlamydia and Gonorrhea annually. While most can be treated with antibiotics, a condition left untreated can cause pelvic Inflammatory disease, complications with pregnancy.